420 with CNW – Why You Should Inform Your Anesthesiologist About Your Cannabis Use

Doctors in Colorado are urging their patients to disclose their cannabis use habits if the patients are due to undergo a surgical procedure regardless of whether that surgery is routine or major surgery.

This call comes after a small study was done on how the medical community was using one common anesthetic drug, propofol, which is used to sedate patients before surgery. The researchers found that on average, the people who used marijuana required approximately thrice the amount of sedation that non-cannabis users required.

These results made the researchers to wonder what additional risks, such as breathing problems, marijuana users may face when they undergo surgery using such high amounts of anesthetics.

In partial response to such concerns, the American Association of Nurse Anesthetists updated the guidelines its members use during their work. The amended guidelines now require anesthetic nurses to take additional steps to keep the airways of marijuana users clear while the patients undergo surgery. Another provision also advises the nurses to refrain from using any anesthetic drugs (sedatives) that could potentially affect the heart rate of marijuana users.

The doctors in Colorado explain that they picked interest in the patients’ use of marijuana because the drug can affect how much sedation should be administered prior to a surgical procedure.

Luckily for the medical professionals in Colorado, marijuana has been legal for years, so patients are unlikely to be guarded about revealing their cannabis use habits. This is because the stigma directed at marijuana users has been knocked back to a great extent.

This open discussion with doctors is timely, because the National Survey on Drug Use and Health done in 2017 indicated that the number of people in Colorado who reported that they had used marijuana at least once within the past 30 days increased to 17 percent from 8 percent in 2006 when a similar survey was done. For comparison, the average past 30-day marijuana use in the country is 9 percent.

The larger proportion of people using marijuana in the state means that more people could be exposed to risks during and after surgery if the patients aren’t forthcoming to their doctors so that appropriate precautions are taken.

While more research may still be needed to ascertain what specific effects marijuana use brings to patients besides requiring larger doses of sedatives, it is in your best interest to let your doctor know even if you live in an area where marijuana is still illegal. The risks of keeping quiet about your marijuana use as you go in for surgery outweigh those of full disclosure.

For now, everyone, including marijuana industry participants like Willow Biosciences Corp. (CSE: WLLW) and Youngevity International Inc. (NASDAQ: YGYI), who minds about people’s health would like the scientific community to speed up their inquiry into what the medical community needs to do to keep marijuana users safe before, during and after undergoing surgery. Otherwise, scaremongers may use the gap to spread unfounded rumors about cannabis use.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Texas State Police Memo Instructs Officers to Stop Cannabis Possession Arrests

An interoffice memo sent to all Department of Public Safety officers in Texas instructs the members of the largest law enforcement agency in the state to stop arresting suspects on marijuana possession charges. This communication marks the most recent twist in the confusion surrounding marijuana law enforcement after lawmakers passed a law legalizing industrial hemp.

The memo instead advises police officers to write a citation asking a suspect to appear in court in order to respond to the criminal charges against him or her. Individuals who receive these citations are still liable to serve a maximum custodial sentence of one year as well as a $4,000 fine for marijuana misdemeanor charges.

The memo adds that department personnel should continue enforcing marijuana laws, but they will only cite and release the suspects.

The interoffice memo, written on July 10, came barely a week before the top Republican leaders in the state (the governor, lieutenant governor and assembly leader) wrote a letter castigating the prosecutors who had either dropped or put marijuana possession cases on hold because of the law legalizing hemp.

In the memo, Randall Prince (deputy director in charge of law enforcement operations, DPS) emphasizes that HB 1325 didn’t decriminalize marijuana, but the change in the law enforcement approach was needed since only a laboratory analysis can prove that a substance is hemp or marijuana.

The difficulty of proving that a substance is hemp and not marijuana is responsible for the decision of many prosecutors to drop marijuana possession cases since the crime labs of the state don’t have the required testing equipment.

However, the DPS memo states that while police officers may be unable to prove beyond reasonable doubt that someone was found in possession of marijuana, it is still possible to find probable cause to institute charges against an individual. The legal burden to prove probable cause is lower than the burden of proving beyond reasonable doubt, and that is why the memo asks officers to issue citations.

That notwithstanding, prosecutors in Tarrant County have decided to send seized samples to a private lab for analysis so that the pending felony cases can proceed. One of the three samples tested was found to have 13 percent THC while another had 15 percent THC. These substances were therefore confirmed to be marijuana while the third sample only contained 0.2 percent THC, which ruled it out as being marijuana.

It isn’t immediately clear how the new directive in the memo will affect marijuana prosecutions given the fact that some exceptions were made in the instructions provided. For example, the cite and release policy directive can only apply if the person suspected to have marijuana is found within the county in which he or she resides. Individuals found outside their counties, such as during traffic stops, will still be arrested.

Secondly, the cite and release policy can only apply in counties where mechanisms are in place to enforce such a measure. For example, a court system should be in place to handle such cases. However, most counties lack the processes needed to enforce the cite and release policy, so the prosecutors in those areas are unlikely to implement this directive.

Commentators wonder what kind of discussions could be taking place in the corridors of industry players like Youngevity International Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) about the marijuana law enforcement chaos in Texas.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Michigan Caregivers Grow More than a Million Marijuana Plants

The registered medical marijuana caregivers in Michigan are authorized to grow more than a million cannabis plants, according to state statistics. This information is crucial as the state transitions from a purely medical cannabis program to one that embraces the recreational use of the drug by adults.

Even if the state accelerates the process by which new commercial growers are licensed, it is unlikely that any of those licensees will have harvested, processed and distributed their marijuana crop at the time recreational sales are launched.

In August 2017, Andrew Brisbo, the Director of the Bureau of Medical Marijuana Regulation stated that approximately 43,000 patients had nominated a caregiver to grow a maximum of 12 cannabis plants for the medical use of the patient.

That statistic means that approximately 1.14 million marijuana plants are under the direct control of the registered caregivers in the state.

Currently, the number of caregivers on the medical marijuana program has risen to an estimated 47,000. This could mean that nearly 1.5 million cannabis plants are grown by these caregivers.

To put this figure in context, the 78 commercial cultivators with state-issued licenses have a 108,000 plant cultivation limit.

All the existing large scale growers and the caregivers currently supply the medical marijuana market whose current patient population stands at 300,000 (Michigan has the second strongest medical marijuana market in the country).

If recreational users come on board, the number of medical marijuana patients will be dwarfed by the number of adults who use cannabis recreationally. Statistics suggest that at least 1.54 million Michigan adults have used recreational marijuana at some point in their lives, so once recreational sales begin, the number of recreational users is likely to be five times that of medical marijuana users.

This means that Michigan could face the same supply shortages that have been witnessed in the states that transition from just medical marijuana markets to recreational cannabis as well. Such supply shortages normally trigger a frenzied expansion of cultivation capacity, which in turn causes a glut once all that extra marijuana finally enters the market.

To prevent the nosedive in prices which results from the glut, Michigan would be well advised to incorporate the caregiver-grown marijuana in the recreational market as well so that the recreational market is kept stable during its first months. This shouldn’t present any quality issues since the caregivers have been supplying the medical cannabis market of the state for years.

Analysts hope that the cannabis industry’s major players in Michigan and elsewhere, such as Youngevity International Inc. (NASDAQ: YGYI) and Willow Biosciences Corp. (CSE: WLLW), will welcome the caregivers whose role provides all-round benefits to all concerned.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Smart Companies Finding Sweet Spot in Cannabis Processing, Manufacturing Opportunities

CannabisNewsWire Editorial Coverage: In between growers and sellers lie several potential places for companies with expertise to firmly establish themselves in the burgeoning cannabis space.

Savvy companies such as Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) recognize the potential payoff of being involved in the back end of the cannabis industry. The company’s wholly owned subsidiary Khrysos Industries Inc. just signed a five-year contract to purchase hemp plant biomass for extraction, end-to-end processing and production of hemp-derived products. Indiva Limited (TSX.V: NDVA) (OTCQX: NDVAF) has successfully received an amended license from Health Canada for three additional grow rooms and three additional processing rooms. Neptune Wellness Solutions Inc. (TSX: NEPT) (NASDAQ: NEPT) recently announced that its wholly owned subsidiary received a notification letter from Health Canada indicating that all requested license amendments have been approved. Other cannabis companies are making strategic moves in the industry as well. CannaRoyalty Corporation (CSE: OH) (OTCQX: ORHOF) has obtained final approval to move forward with its plan of arrangement with Cresco Labs, which will result in the largest-ever public company acquisition in the U.S. cannabis sector. And KushCo Holdings Inc. (OTCQX: KSHB) has partnered with C.A. Fortune, a leading full-service national consumer products sales and marketing agency, with the intent to grant…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Senate Could Hold Hearings on Cannabis Banking Later this Month

The Senate Banking Committee could schedule hearings on bipartisan legislation on cannabis banking in as little as two weeks. This revelation was made by the chairman of that committee, Mike Crapo (R-ID) as he talked to American Banker.

Crapo said that he was looking into the prospect of scheduling a hearing on the matter and added that the hearings will be “relatively soon.”

This statement marks a huge change of heart for the senator from Idaho who is on record saying (in April) that he wouldn’t commit his committee to holding sessions on marijuana banking as long as marijuana is still illegal at the federal level.

Banking industry insiders believe that the committee is likely to have two hearings in the week starting July 22. One hearing will be centered on hearing from the regulators of the banking sector while the second hearing will listen to the other stakeholders on this matter.

A similar bill was passed by the Congressional Banking Services Committee in March and similar language to the contents of the STATES Act was included in the appropriations bill.

While pro-cannabis advocates have been hoping that the STATES Act is put on the schedule for a vote by the entire House before the legislative chamber goes for recess in August, this hasn’t happened as yet. It now seems that a vote on the bill may have to wait until the fall.

Concerns have also been voiced about how the STATES Act would be received once it gets to a Senate that is dominated by Republicans.

Rep. Ed Perlmutter (D-CO), the chief sponsor of the House version of the bill, revealed that lawmakers are currently exploring other ways to generate Republican support for the bill. One of the avenues being explored is including language to the effect that regulators will not prevent payday lenders and gun manufacturers from accessing banking services.

Another avenue that could be used is the inclusion of language that protects the hemp industry so that Republicans don’t look at that the bill as one on just marijuana.

A senate hearing on marijuana business banking would mark another milestone for those who want to see marijuana policy reform. While the STATES Act will not alter the status of marijuana federally, it is a step in the right direction since many advocates see the incremental approach to legalization as a more realistic option when compared to the chances of a standalone bill on legalization passing in both chambers.

Industry watchers believe that the entire cannabis industry, including Cannabis Strategic Ventures Inc. (OTCQB: NUGS) and Youngevity International Inc. (NASDAQ: YGYI), will be waiting with bated breath to hear what comes out from the Senate committee hearings.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Maine Recreational Marijuana Regulations Signed

Back in 2016, voters passed a measure to legalize recreational marijuana in Maine. Since then, residents have been waiting for the state government to draft and pass regulations which would operationalize recreational cannabis cultivation, manufacture and sales. Gov. Janet Mills has now signed the regulations and brings the long wait to an end.

These guidelines will take effect in September and the first recreational cannabis sales could begin early next year.

Speaking at the signing ceremony, Gov. Mills remarked that the rules show what can happen when the government works with legislators, industry players and members of the public to attain a common goal. She added that this law brings the state ever so close to making the people’s wish of legalizing recreational marijuana a reality.

One of the clauses in the regulatory framework states that any marijuana company which wishes to be licensed in the state must have a resident who has lived in Maine for at least four years as the majority shareholder with an ownership stake that isn’t less than 51 percent. This requirement will remain in force until June 2021.

The law also contains restrictions on who can sell marijuana in the state. Anyone who has been convicted for any offense related to drugs (even if that drug isn’t marijuana) within the past 10 years and those who have ever had their marijuana license revoked anywhere in the U.S. aren’t eligible for a marijuana sales license in Maine.

Local authorities have also been allowed to decide whether recreational marijuana businesses can open within their jurisdictions or not. So far, only a paltry 15 out of the 455 municipalities in the state have expressed interest in licensing recreational cannabis businesses.

This low interest is understandable from two key perspectives. First, the ballot measure which saw the legalization of marijuana was passed by a slim majority of voters. If voter sentiments haven’t changed much since 2016, it is reasonable to expect that a sizeable number of municipalities (and the residents therein) will be opposed to recreational marijuana.

Secondly, many municipalities have been waiting on the state government to pass the regulatory framework before they can decide whether to opt in or out of the recreational industry. Now that the rules are out, the vast majority of municipalities in this category will make their position known by the time recreational sales officially begin.

Marijuana industry watchers are wondering what industry players like Youngevity International Inc. (NASDAQ: YGYI) and Willow Biosciences Inc. (CSE: WLLW) think about this regulatory framework, which has become law in Maine.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Congress Votes to Stop Feds from Interfering in State Marijuana Programs

The House of Representatives has voted to block the Department of Justice (DOJ) from using its funds to enforce federal cannabis laws within states which have passed their own laws regulating recreational or medical marijuana cultivation, consumption and sales.

This measure was one of the several amendments put before the floor for inclusion in the appropriations bill for Fiscal Year 2020. The measure, which expands an existing rider that protected medical marijuana programs, was approved on Thursday by a 267-165 vote.

Marijuana industry advocates are convinced that the vote tally reflects the broad support for marijuana law reform, and this support can be used to effect further reforms of the federal marijuana laws.

A day earlier (June 19), the House had also passed another measure seeking to protect the marijuana laws of Indian tribes. This particular measure was passed through a voice vote without any lawmaker asking for a roll call vote. The rider now makes it to the appropriations bill as well.

Rep. McClintock, one of the sponsors of the measure which was approved on Thursday, wrote a letter to members of the House on the day of the vote reminding them that what was at stake was a question on whether the federal government had any authority to dictate on matters of policy regarding an issue which happens within the borders of a state. In his view, which other members appear to have agreed with from the way they voted, the federal government didn’t have that constitutional authority.

Marijuana Policy Project, Drug Policy Alliance, Cannabis Trade Federation, and other marijuana advocacy groups hailed the decision of Congress as historical and a sign that lawmakers in the House of Representatives are waking up to the fact that marijuana law reform “isn’t just good policy but has also become good politics.”

It has emerged that the makers of the only CBD-derived drug to be approved by the FDA wrote to congressional staff telling them that the spending rider before the House should be defeated since it “could interfere with the DOJ’s ability to carry out its regulatory mandate.” The letter from Greenwich Biosciences was seen as being in bad taste since the “Big Pharma” company wanted to protect its interests at the expense of the interests of the people in states with marijuana-friendly laws.

The measures now head to the Appropriations Committee of Senate for consideration, and it isn’t yet clear whether they will be favorably received there. In the past, this committee has consistently approved the spending rider stopping DOJ from interfering in state-level medical marijuana programs. Now that the new amendments include protections for recreational marijuana, the industry isn’t sure how the Republicans in the Senate Committee will react.

Industry analysts are wondering what players like Youngevity International Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) would say to the senators if they had a chance to talk to them before they vote on the amendments.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Why Columbia Could Reshape the Canadian Cannabis Landscape

The big pot stocks in Canada, such as Tilray Inc., Canopy Growth Corp. and Aurora Cannabis may soon have to contend with an emerging threat as marijuana growers in North America start moving their farms across the border to Columbia.

This migration is eerily similar to what happened to the growers of rose flowers who all moved south to low-cost Columbia.

Paul Henderson, the owner of Grupo Flor (a cannabis cultivation company based in Monterey) is the trailblazer of this migration. He predicts that North American marijuana growers in Canada will suffer the same fate that rose growers experienced. Practically no rose grower was left in Monerey once cultivation starting moving south.

Henderson adds that within the next decade, the cannabis industry will transition into a phase of commoditization. As that happens, it will become increasingly untenable to keep growing marijuana in Canada when Columbia is just a short distance away.

Henderson’s company is currently getting a 1,000,000 square-foot cultivation facility ready on the outskirts of Cali, a city found close to the Equator in Columbia. He boasts that when the facility starts operations, his company would be able to cut the price of its produce by 90 percent and still make a profit, something that growers who are still based in Canada cannot do and stay afloat.

Columbia enjoys several advantages which are only a dream to Canadian cannabis growers. First, the climate in Columbia is so good that the cultivation facilities there don’t require elaborate climate-control systems. Secondly, the labor in Columbia is highly skilled yet more affordable than what is available in Canada.

These reduced production costs put Columbia firmly on course to attain the target of producing a gram of cannabis at just 50 Canadian cents ($0.38) and yet the long-term goal of cannabis production in Canada is to bring the cost of a gram down to CAD $2 ($1.51) . That is a whole world of difference in production costs!

Columbia legalized medical cannabis for domestic use as well as export. This policy shift is responsible for the interest of Canadian cannabis growers in shifting their operations to Columbia.

The emergence of Columbia as a destination for Canadian cannabis cultivators has come at a time when the cannabis industry in Canada has just been dealt a blow by the U.S. FDA. The regulators are reluctant to legalize CBD and it appears to be headed for regulatory oversight by the FDA. This has dampened the hopes of Canadian firms that were gearing up to enter the U.S. CBD market.

Cannabis industry watchers are wondering what major players like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Youngevity International Inc. (NASDAQ: YGYI) can do to respond to developments like transferring marijuana cultivation facilities to another country different from the country where the company has its major operations.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Arizona Medical Cannabis Dispensaries Celebrate Supreme Court Decision on Concentrates as Sales Soar

In a 7-0 emphatic decision, the Supreme Court of Arizona has quashed a ruling by the Court of Appeal to the effect that marijuana concentrates, such as hashish, were not included in the law which legalized medical marijuana in the state.

This case arose after Yavapai County convicted a patient with a valid medical marijuana card issued by the state for possessing hashish. In their ruling delivered on Tuesday (May 28), the justices affirmed that the law legalized all forms of the cannabis plant, including the concentrates made from any segments of the plant that manufacturers deemed fit for processing.

For over a year, the decision of the Court of Appeal had stood and restricted the potentially explosive growth of the cannabis concentrates industry since the court ruling had excluded concentrates from the products envisaged by the 2010 law.

The cannabis extracts sold in medical marijuana dispensaries across the state include soda, candy, vape pens, food and many other products. Records show that the sale of cannabis concentrates is growing at a faster pace when compared to marijuana flower. For example, in the year ending April 2019, sales of cannabis flower grew by 33 percent while sales of concentrates surged by 71 percent in the same period. The 71 percent growth doesn’t include cannabis edibles.

It would therefore have been damaging (and strange) if the highest court has upheld the decision of the lower court. Many jurisdictions where medical marijuana is legal only allow extracts, such as cannabis oil, tinctures, creams, gels and ointments. These include Pennsylvania which only accepted smokable cannabis recently.

It is noteworthy that the dispensaries and manufacturers, such as Item 9 Labs, only paused cannabis concentrate sales briefly after the Court of Appeal ruling and then continued business as usual after their legal teams advised them that there was no legal basis for banning the concentrates.

The legal counsel of those companies has now been vindicated after the Supreme Court pronounced itself on the matter.

Patients have welcomed the latest ruling since the decision ensures that they will continue accessing marijuana concentrates. Many of the patients on the medical marijuana program are either unable or unwilling to smoke medical marijuana. Concentrates also provide a precise way to determine the dosage consumed, an attribute which is vital if the desired therapeutic effects are to be attained.

Lindsey Bartels, a patient who lives in Tempe and has battled chronic pain for years, admitted as much when she said cannabis oil allows her to live a normal life. Youngevity International Inc. (NASDAQ: YGYI), Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and the entire cannabis industry welcomes the court decision in Arizona which has given patients like Lindsey Bartels hope that they will continue having access to cannabis concentrates which have proved immensely helpful in improving the quality of their lives.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – University of Washington to Study Effects of Cannabis Use During Pregnancy

There’s minimal scientific information about the potential effects of the different drugs which pregnant mothers are discouraged from taking, but cannabis is singled out and given a very negative connotation even if there’s no proof to show whether it is as dangerous, or more dangerous, than pharmaceutical drugs. To set the record straight, researchers from the University of Washington are now recruiting study subjects to research how cannabis use during pregnancy affects babies after they are born.

The “Moms + Marijuana” study will document pregnant mothers’ use of marijuana from the first trimester of pregnancy until birth. The babies born will then have their brains scanned at six months of age to determine how prenatal marijuana use affects the cognitive, psychomotor and behavioral development of infants.

The study is focusing on pregnant women who are already using cannabis to manage the conditions, such as nausea, which they are suffering from during pregnancy. The objective is to find scientific proof either in support of, or contradicting the advice given to pregnant women to abstain from using marijuana.

To this end, the researchers are on a drive to recruit 70 pregnant women who are still in the first trimester of pregnancy. Half of these women will be in the test group while the other half will be in the control group.

Those in the control group will not be allowed to take any cannabis, tobacco or alcohol while those in the test group will be allowed to consume marijuana at least two times each week. The marijuana will be used to control morning sickness.

The researchers intend to conduct random drugs tests throughout the study in order to confirm that the pregnant women aren’t using any other drugs apart from what they are self-reporting to the researchers.

The test group of pregnant women are required to report their weekly marijuana use, and that marijuana can only be bought from licensed sources. The women will also send photos of the cannabis package so that the THC and CBD concentration in that marijuana will be recorded.

When the babies of the research subjects reach six months of age, they will be tested to establish their social and cognitive development, their motor and communication skills, their temperament and other behavioral markers.

Magnetic Resonance Imaging (MRI) scans will also be done while the babies are asleep. During those scans, the babies will be exposed to an odor of phenyl-ethanol. This substance is known to activate the sections of the brain which are associated with addiction and reward. The researchers want to use these scans to assess how prenatal marijuana use affects this part of the brain.

Once all this data has been collected, the researchers will compare the findings from the two groups and determine what role marijuana has had on the development of the babies. Youngevity International Inc. (NASDAQ: YGYI) and Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) hope that this research will provide conclusive proof of whether prenatal cannabis use should or shouldn’t be recommended.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com